» Articles » PMID: 25887856

AMPD1 Regulates MTORC1-p70 S6 Kinase Axis in the Control of Insulin Sensitivity in Skeletal Muscle

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2015 Apr 19
PMID 25887856
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Insulin resistance triggered by excess fat is a key pathogenic factor that promotes type 2 diabetes. Understanding molecular mechanisms of insulin resistance may lead to the identification of a novel therapeutic target for type 2 diabetes. AMPD1, an isoform of AMP deaminase (AMPD), is suggested to play roles in the regulation of glucose metabolism through controlling AMP-activated protein kinase (AMPK) activation. We reported that the diet-induced insulin resistance was improved in AMPD1-deficient mice compared to wild type mice. To further delineate this observation, we studied changes of insulin signaling in skeletal muscle of wild type (WT) and AMPD1-deficient mice.

Methods: Phosphorylation levels of kinases and expression levels of mTOR components were quantified by immunoblotting using protein extracts from tissues. The interaction between mTOR and Raptor was determined by immunoblotting of mTOR immunoprecipitates with anti-Raptor antibody. Gene expression was studied by quantitative PCR using RNA extracted from tissues.

Results: Phosphorylation levels of AMPK, Akt and p70 S6 kinase in skeletal muscle were higher in AMPD1-deficient mice compared to WT mice after high fat diet challenge, while they did not show such difference in normal chow diet. Also, no significant changes in phosphorylation levels of AMPK, Akt or p70 S6 kinase were observed in liver and white adipose tissue between WT and AMPD1-deficient mice. The expression levels of mTOR, Raptor and Rictor tended to be increased by AMPD1 deficiency compared to WT after high fat diet challenge. AMPD1 deficiency increased Raptor-bound mTOR in skeletal muscle compared to WT after high fat diet challenge. Gene expression of peroxisome proliferator-activated receptor-γ coactivator 1α and β, downstream targets of p70 S6 kinase, in skeletal muscles was not changed significantly by AMPD1 deficiency compared to the wild type after high fat diet challenge.

Conclusion: These data suggest that AMPD1 deficiency activates AMPK/Akt/mTORC1/p70 S6 kinase axis in skeletal muscle after high fat diet challenge, but not in normal chow diet. These changes may contribute to improve insulin resistance.

Citing Articles

Role of AMP deaminase in diabetic cardiomyopathy.

Miura T, Kouzu H, Tanno M, Tatekoshi Y, Kuno A Mol Cell Biochem. 2024; 479(12):3195-3211.

PMID: 38386218 DOI: 10.1007/s11010-024-04951-z.


Molecular characterization of adenosine monophosphate deaminase 1 and its regulatory mechanism for inosine monophosphate formation in triploid crucian carp.

Zhou Y, Zuo A, Li Y, Zhang Y, Yi Z, Zhao D Front Physiol. 2022; 13:970939.

PMID: 36111156 PMC: 9468423. DOI: 10.3389/fphys.2022.970939.


Skeletal muscle contraction kinetics and AMPK responses are modulated by the adenine nucleotide degrading enzyme AMPD1.

Hafen P, Law A, Matias C, Miller S, Brault J J Appl Physiol (1985). 2022; 133(5):1055-1066.

PMID: 36107988 PMC: 9602816. DOI: 10.1152/japplphysiol.00035.2022.


Circulating Very-Long-Chain SFA Concentrations Are Inversely Associated with Incident Type 2 Diabetes in US Men and Women.

Ardisson Korat A, Malik V, Furtado J, Sacks F, Rosner B, Rexrode K J Nutr. 2019; 150(2):340-349.

PMID: 31618417 PMC: 7308624. DOI: 10.1093/jn/nxz240.


Heat Shock Proteins as a Potential Therapeutic Target in the Treatment of Gestational Diabetes Mellitus: What We Know so Far.

Skorzynska-Dziduszko K, Kimber-Trojnar Z, Patro-Malysza J, Stenzel-Bembenek A, Oleszczuk J, Leszczynska-Gorzelak B Int J Mol Sci. 2018; 19(10).

PMID: 30336561 PMC: 6213996. DOI: 10.3390/ijms19103205.


References
1.
Kim D, Sarbassov D, Ali S, King J, Latek R, Erdjument-Bromage H . mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 2002; 110(2):163-75. DOI: 10.1016/s0092-8674(02)00808-5. View

2.
Handschin C, Spiegelman B . Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev. 2006; 27(7):728-35. DOI: 10.1210/er.2006-0037. View

3.
Safranow K, Czyzycka E, Binczak-Kuleta A, Rzeuski R, Skowronek J, Wojtarowicz A . Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure. Scand J Clin Lab Invest. 2008; 69(1):102-12. DOI: 10.1080/00365510802430964. View

4.
Safranow K, Suchy J, Jakubowska K, Olszewska M, Binczak-Kuleta A, Kurzawski G . AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases. J Appl Genet. 2010; 52(1):67-76. PMC: 3026686. DOI: 10.1007/s13353-010-0009-x. View

5.
Bostrom P, Wu J, Jedrychowski M, Korde A, Ye L, Lo J . A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012; 481(7382):463-8. PMC: 3522098. DOI: 10.1038/nature10777. View